A part of Merck

341205 | Etoposide - CAS 33419-42-0 - Calbiochem

341205
No pudo obtenerse el precio
La cantidad mínima tiene que ser múltiplo de
Al finalizar el pedido Más información
Ahorró ()
 
Solicitar precio
Disponibilidad a confirmarDisponibilidad a confirmar
En existencia 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Ver precios y disponibilidad
      Click To Print This Page

      Descripción

      Replacement Information

      Tabla espec. clave

      Empirical FormulaCAS #
      C₂₉H₃₂O₁₃ 33419-42-0

      Precios y disponibilidad

      Número de referenciaDisponiblidad Embalaje Cant./Env. Precio Cantidad
      US1341205-25MG
      Comprobando disponibilidad...
      Disponibilidad a confirmarDisponibilidad a confirmar
      En existencia 
      Suspendido
      Cantidades limitadas disponibles
      Debe confirmarse disponibilidad
        El resto: se avisará
          El resto: se avisará
          Se avisará
          Póngase en contacto con el Servicio de Atención al Cliente

          Frasco de vidrio 25 mg
          Recuperando precio...
          No pudo obtenerse el precio
          La cantidad mínima tiene que ser múltiplo de
          Al finalizar el pedido Más información
          Ahorró ()
           
          Solicitar precio
          Description
          OverviewA cell-permeable derivative of podophyllotoxin that acts as a topoisomerase II inhibitor (IC50 = 59.2 µM) has major activity against a number of tumors, including germ cell neoplasms, small cell lung cancer, and malignant lymphoma. Induces apoptosis in mouse thymocytes and in HL-60 human leukemia cells.
          Catalogue Number341205
          Brand Family Calbiochem®
          SynonymsVP-16
          References
          ReferencesDe Lange, A.M., et al. 1995. J. Virol. 69, 2082.
          Kaufman, S.H., et al. 1993. Cancer Res. 53, 3976.
          Onishi, Y., et al. 1993. Biochim. Biophys. Acta 1175, 147.
          Terada, T., et al. 1993. J. Med. Chem. 36, 1689.
          Wazniak, A.J., et al. 1991. J. Clin. Oncol. 9, 70.
          Einhorn, L.H., et al. 1988. J. Clin. Oncol. 6, 451.
          Issel, B.F. 1982. Cancer Chemother. Pharmacol. 7, 73.
          Product Information
          CAS number33419-42-0
          ATP CompetitiveN
          FormWhite solid
          Hill FormulaC₂₉H₃₂O₁₃
          Chemical formulaC₂₉H₃₂O₁₃
          ReversibleN
          Structure formula Image
          Applications
          ApplicationEtoposide, CAS 33419-42-0, is cell-permeable inhibitor of topoisomerase II inhibitor (IC50 = 59.2 µM). Displays anti-tumor activity.
          Biological Information
          Primary Targettopoisomerase 2
          Primary Target IC<sub>50</sub>59.2 µM inhibiting topoisomerase II
          Purity>97% by HPLC
          Physicochemical Information
          Cell permeableY
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          RTECSKC0190000
          Safety Information
          R PhraseR: 22-45

          Harmful if swallowed.
          May cause cancer.
          S PhraseS: 26-36/37/39-45-53

          In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
          Wear suitable protective clothing, gloves and eye/face protection.
          In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).
          Avoid exposure - obtain special instructions before use.
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Harmful & Carcinogenic / Teratogenic
          Storage +15°C to +30°C
          Protect from Light Protect from light
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          Ficha datos de seguridad (MSDS)

          Título

          Ficha técnica de seguridad del material (MSDS) 

          Certificados de análisis

          CargoNúmero de lote
          341205

          Referencias bibliográficas

          Visión general referencias
          De Lange, A.M., et al. 1995. J. Virol. 69, 2082.
          Kaufman, S.H., et al. 1993. Cancer Res. 53, 3976.
          Onishi, Y., et al. 1993. Biochim. Biophys. Acta 1175, 147.
          Terada, T., et al. 1993. J. Med. Chem. 36, 1689.
          Wazniak, A.J., et al. 1991. J. Clin. Oncol. 9, 70.
          Einhorn, L.H., et al. 1988. J. Clin. Oncol. 6, 451.
          Issel, B.F. 1982. Cancer Chemother. Pharmacol. 7, 73.
          Ficha técnica

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision02-May-2008 RFH
          SynonymsVP-16
          DescriptionA cell-permeable, topoisomerase II inhibitor (IC50 = 59.2 µM). A derivative of podophyllotoxin (Cat. No. 540040) that has major activity against a number of tumors, including germ cell neoplasms, small cell lung cancer, and malignant lymphoma. Induces apoptosis in mouse thymocytes and in HL-60 human leukemia cells.
          FormWhite solid
          CAS number33419-42-0
          RTECSKC0190000
          Chemical formulaC₂₉H₃₂O₁₃
          Structure formula
          Purity>97% by HPLC
          SolubilityDMSO (25 mg/ml)
          Storage +15°C to +30°C
          Protect from light
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
          Toxicity Harmful & Carcinogenic / Teratogenic
          Merck USA index14, 3886
          ReferencesDe Lange, A.M., et al. 1995. J. Virol. 69, 2082.
          Kaufman, S.H., et al. 1993. Cancer Res. 53, 3976.
          Onishi, Y., et al. 1993. Biochim. Biophys. Acta 1175, 147.
          Terada, T., et al. 1993. J. Med. Chem. 36, 1689.
          Wazniak, A.J., et al. 1991. J. Clin. Oncol. 9, 70.
          Einhorn, L.H., et al. 1988. J. Clin. Oncol. 6, 451.
          Issel, B.F. 1982. Cancer Chemother. Pharmacol. 7, 73.